STRATA Enterprise Value Over E B I T D A from 2010 to 2024

SSKN Stock  USD 3.05  0.05  1.61%   
STRATA Skin Enterprise Value Over EBITDA yearly trend continues to be very stable with very little volatility. Enterprise Value Over EBITDA is likely to drop to -8.72. During the period from 2010 to 2024, STRATA Skin Enterprise Value Over EBITDA quarterly data regression pattern had sample variance of  6,992 and median of (1.03). View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
(8.30)
Current Value
(8.72)
Quarterly Volatility
83.62006582
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check STRATA Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among STRATA Skin's main balance sheet or income statement drivers, such as Total Revenue of 19.5 M, Gross Profit of 11.1 M or Other Operating Expenses of 22.8 M, as well as many indicators such as Price To Sales Ratio of 0.55, Dividend Yield of 0.0 or PTB Ratio of 1.59. STRATA financial statements analysis is a perfect complement when working with STRATA Skin Valuation or Volatility modules.
  
Check out the analysis of STRATA Skin Correlation against competitors.

Latest STRATA Skin's Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of STRATA Skin Sciences over the last few years. It is STRATA Skin's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in STRATA Skin's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Very volatile
   Enterprise Value Over E B I T D A   
       Timeline  

STRATA Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean(22.10)
Geometric Mean9.40
Coefficient Of Variation(378.35)
Mean Deviation47.25
Median(1.03)
Standard Deviation83.62
Sample Variance6,992
Range344
R-Value0.03
Mean Square Error7,523
R-Squared0.001
Significance0.91
Slope0.59
Total Sum of Squares97,892

STRATA Enterprise Value Over E B I T D A History

2024 -8.72
2023 -8.3
2022 26.98
2021 26.23
2020 -307.23
2019 37.03
2018 30.14

About STRATA Skin Financial Statements

STRATA Skin investors utilize fundamental indicators, such as Enterprise Value Over E B I T D A, to predict how STRATA Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA(8.30)(8.72)

Pair Trading with STRATA Skin

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STRATA Skin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRATA Skin will appreciate offsetting losses from the drop in the long position's value.

Moving against STRATA Stock

  0.61CVS CVS Health Corp Aggressive PushPairCorr
  0.35PHG Koninklijke PhilipsPairCorr
  0.32FIGS Figs IncPairCorr
The ability to find closely correlated positions to STRATA Skin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STRATA Skin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STRATA Skin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STRATA Skin Sciences to buy it.
The correlation of STRATA Skin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STRATA Skin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STRATA Skin Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for STRATA Skin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Check out the analysis of STRATA Skin Correlation against competitors.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.60)
Revenue Per Share
9.347
Quarterly Revenue Growth
0.022
Return On Assets
(0.07)
Return On Equity
(0.63)
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.